- Women are twice as likely as men to develop Alzheimer's disease, accounting for almost two-thirds of American sufferers.
- Scientists are investigating two primary biological differences: chromosomal variations, particularly genes on the X chromosome.
- The natural decline of reproductive hormones during menopause is also considered a significant factor contributing to women's increased risk.
- Research suggests that women who received hormone replacement therapy after age 70 exhibited higher levels of the Alzheimer's hallmark protein “tau” and greater cognitive decline.
- Further studies are required to fully comprehend the complex associations between menopause, hormonal changes, and the long-term risk of developing Alzheimer's.
IN FULL